Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

EvoLV's Approach to Healthcare Technology Solutions: A Case Study

Feb 21, 2025

Introduction to EvoLV's Healthcare Solutions

In an era where technology is reshaping every facet of our lives, healthcare stands as one of the most critical sectors undergoing transformation. EvoLV has emerged as a key player in this revolution, offering innovative technology solutions that enhance patient care and operational efficiency. This case study examines how EvoLV approaches healthcare technology and the impact it has had on its clients.

healthcare technology

The Core Philosophy of EvoLV

EvoLV's approach to healthcare technology is rooted in the belief that patient-centric solutions are paramount. By focusing on the needs and experiences of patients, EvoLV develops products that are not only technologically advanced but also user-friendly. This philosophy ensures that the technology aids rather than complicates the healthcare process.

Moreover, EvoLV emphasizes interoperability. In a field where different systems often need to communicate seamlessly, EvoLV ensures its solutions can integrate with existing technologies. This approach minimizes disruptions and enhances the overall efficiency of healthcare facilities.

Innovative Solutions Offered

EvoLV's product suite includes a variety of solutions designed to address specific healthcare challenges. Key offerings include:

  • Electronic Health Records (EHR) Systems: Streamlining patient data management for improved accuracy and accessibility.
  • Telemedicine Platforms: Facilitating remote consultations to enhance accessibility for patients in remote areas.
  • AI-Powered Diagnostics Tools: Assisting healthcare professionals in making faster and more accurate diagnoses.
medical innovation

Case Study: Transformative Impact on a Healthcare Facility

One notable case involves EvoLV's partnership with a mid-sized hospital aiming to modernize its operations. The hospital faced challenges with data management, patient wait times, and resource allocation. EvoLV implemented its full suite of solutions, resulting in remarkable improvements.

The implementation of EvoLV's EHR system reduced data entry errors by 30% and decreased patient wait times by 20%. Additionally, the telemedicine platform expanded the hospital's reach, allowing it to serve an additional 15% of patients remotely.

Feedback from Healthcare Professionals

Feedback from healthcare professionals using EvoLV's solutions has been overwhelmingly positive. Doctors and nurses appreciate the intuitive design of the interfaces, which reduces the learning curve and allows them to focus more on patient care. A doctor at the partner hospital mentioned, "EvoLV’s technology has streamlined our daily operations, making it easier to provide quality care efficiently."

healthcare professionals

Challenges and Adaptations

Despite its successes, EvoLV acknowledges that implementing new technology in healthcare is not without challenges. Resistance to change and budget constraints are common barriers. However, EvoLV addresses these issues by offering comprehensive training programs and flexible financing options to ensure a smooth transition.

EvoLV also continuously adapts its solutions based on feedback from users, ensuring that the technology evolves alongside the needs of healthcare providers.

The Future of Healthcare Technology with EvoLV

Looking ahead, EvoLV is committed to pushing the boundaries of what's possible in healthcare technology. The company is investing in research and development to explore emerging technologies like blockchain for secure patient data management and virtual reality for enhanced medical training.

By staying at the forefront of innovation, EvoLV aims to continue delivering transformative solutions that not only improve healthcare outcomes but also align with the rapidly changing landscape of the medical field.

Conclusion

EvoLV's approach to healthcare technology showcases how innovative solutions can lead to significant improvements in patient care and operational efficiency. By prioritizing patient-centric designs, interoperability, and continuous adaptation, EvoLV stands as a model for how technology can be effectively integrated into healthcare. As the company looks to the future, its commitment to excellence and innovation promises even greater advancements in the years to come.